Treatment of Benign Prostatic Hyperplasia
Copyright policy )Treatment of Benign Prostatic Hyperplasia
Lower urinary tract symptoms (LUTS) may be a sign of aging rather than a consequence of benign prostatic enlargement (BPE) or benign prostatic obstruction (BPO). Medical or invasive treatments should address the bothersome symptoms and the quality of life of patients. Alpha blockers and 5-alpha reductase inhibitors are most frequently used in benign prostatic hyperplasia (BPH) medical treatments, whereas Transurethral Resection of the Prostate (TURP) remains the "gold standard" for surgical treatments. Several minimal invasive treatments are emerging with promising outcomes.
Male, 5-alpha Reductase Inhibitors, Treatment Outcome, Prostatic Hyperplasia, Transurethral Resection of Prostate, Humans, Minimally Invasive Surgical Procedures, Laser Therapy, Adrenergic alpha-Antagonists
Male, 5-alpha Reductase Inhibitors, Treatment Outcome, Prostatic Hyperplasia, Transurethral Resection of Prostate, Humans, Minimally Invasive Surgical Procedures, Laser Therapy, Adrenergic alpha-Antagonists
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).24 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 10% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
Citations provided by BIP!Popularity provided by BIP!